
Virtual Congress 2.0
POET Virtual Congress 2.0 Agenda
THURSDAY, OCTOBER 22
|
|
9:00AM- 11:30AM MT | AM Session 1: Clinical Trials Design in Precision Oncology Session Chair: Dr. Rosalyn Juergens |
9:00AM- 9:05AM | Welcome to the POET Virtual Congress 2.0 – Dr. Gwyn Bebb |
9:05AM- 9:10AM | Welcome from the University of Calgary – Dr. Ed McCauley |
9:10AM- 9:15AM | Welcome from Cancer Care Alberta – Dr. Paula Robson |
9:15AM- 9:45AM |
Lessons from biomarker-based clinical trials – Dr. David Hong |
9:45AM- 10:05AM |
Novel marker discovery in the pre-clinical trials design – Dr. Charles Ricordel |
10:05AM- 10:25AM |
Novel marker discovery moving into clinical trials design – Dr. Lori Kunkel |
10:25AM- 10:55AM |
Panel: Hot Topic Debate |
10:55AM- 11:25AM | Questions & Discussion |
11:25AM – 11:30AM | Closing Session Remarks – Dr. Gwyn Bebb |
5:00PM- 8:00PM MT | PM Session 2: Immuno-Oncology and Precision Oncology Session Chair: Dr. Doug Mahoney |
5:00PM- 5:05PM | Welcome to the POET Virtual Congress 2.0 – Dr. Pinaki Bose |
5:05PM- 5:10PM | Welcome from University of Calgary and Alberta Health Services Oncology Department – Dr. Don Morris |
5:10PM- 5:30PM | Oncolytic virus therapy – Dr. Doug Mahoney |
5:30PM- 6:00PM | Innovations in CAR-T therapy – Dr. Brad Nelson |
6:00PM- 6:20PM | Role of Cytokine Profiling in Immuno-Oncology – Dr. Faisal Khan |
6:20PM- 6:40PM | Genes in Space: A Histological Perspective of Gene Expression in OSCC – Dr. Pinaki Bose |
6:40PM- 7:00PM | Proteomics in precision oncology – Dr. Sorana Morrissy |
7:00PM- 7:30PM | Panel: Hot Topic Debate – How can the cost of immune-modulating interventions be reduced in the next 10 years? – What is the best predictive biomarker for immunotherapy? |
7:30PM – 8:00PM | Questions & Discussions |
8:00PM- 8:05PM | Closing Session Remarks – Dr. Pinaki Bose |
FRIDAY, OCTOBER 23
|
|
9:00AM – 11:15AM MT | AM Session 3: Adoption of genomics for clinical decision making Across Canada Session Chair: Dr. Steven Jones |
9:00AM- 9:05AM | Welcome to the POET Virtual Congress 2.0 – Dr. Pinaki Bose |
9:05AM- 9:10AM | Welcome from Arnie Charbonneau Cancer Institute – Dr. Greg Cairncross |
9:10AM- 9:30AM | Canadian NGS programs supporting access to profiling and clinical decision making – Dr. Steven Jones |
9:30AM- 9:50AM | EXACTIS perspectives of supporting phase 1 clinical trials – Dr. Gerald Batist |
9:50AM- 10:10AM | The economics of NGS in precision oncology – Dr. Dean Regier |
10:10AM- 10:40AM | Panel: Hot Topic Debate – What is the main challenge to the adoption of broad panel-based NGS testing in solid tumour patients? – Is it necessary to build NGS testing infrastructure in Canada or is it best to send samples out of the country for testing? – What level of RWE is required for justifying NGS adoption by health care providers? – How can industry partner with (a) academia and (b)other private sector stakeholders to accelerate the adoption of NGS? |
10:40AM- 11:10AM | Questions & Discussions |
11:10AM- 11:15AM | Closing Session Remarks – Dr. Pinaki Bose |
5:00PM – 8:00PM MT | PM Session 4: Microbiome in Precision Oncology Session Chair: Dr. Kathy McCoy |
5:00PM- 5:05PM | Welcome to the POET Virtual Congress 2.0 – Dr. Gwyn Bebb |
5:05PM – 5:25PM | Microbiome in Oncology at the Calgary International Microbiome Centre – Dr. Kathy McCoy |
5:25PM – 5:55PM | Pathogenesis of microbial biofilms in colorectal cancer – Dr. Julia Drewes |
5:55PM – 6:25PM | Microbiome as a predictor of Hematopoietic Stem Cell Transplant Outcomes – Dr. Jonathan Peled |
6:25PM – 6:55PM | Role of the microbiome in ovarian and endometrial cancers to lead to predictive and early detection tests, and intervention before cancer develops – Dr. Marina Walther-Antonio |
6:55PM – 7:25PM | Panel: Hot Topic Debate – Do we really believe that the microbiome influences treatment outcome? – How do we design clinical trials that investigate modulating the microbiome as a cancer management intervention? – Do antibiotics have a role to play in modulating the microbiome to improve cancer treatments? |
7:25PM – 7:55PM | Questions & Discussions |
7:55PM – 8:00PM | Closing Remarks – Dr. Gwyn Bebb |
